Spectrum of Malignant Pleural and Pericardial Disease on FDG PET/CT

被引:15
|
作者
Makis, William [1 ]
Ciarallo, Anthony [2 ]
Hickeson, Marc [2 ]
Rush, Christopher [3 ]
Novales-Diaz, Javier A. [2 ]
Derbekyan, Vilma [2 ]
Laufer, Jerome [3 ]
Stern, Jerry [3 ]
Lisbona, Robert [2 ]
机构
[1] Brandon Reg Hlth Ctr, Dept Nucl Med, Brandon, MB R7A 2B3, Canada
[2] McGill Univ, Royal Victoria Hosp, Dept Nucl Med, Montreal, PQ H3A 1A1, Canada
[3] McGill Univ, Jewish Gen Hosp, Dept Nucl Med, Montreal, PQ H3T 1E2, Canada
关键词
FDG; malignancy; pericardial; PET/CT; pleural; POSITRON-EMISSION-TOMOGRAPHY; PRIMARY EFFUSION LYMPHOMA; METASTATIC INVOLVEMENT; COMPUTED-TOMOGRAPHY; HODGKIN-LYMPHOMA; LUNG-CANCER; MESOTHELIOMA; CT; MANAGEMENT; ABNORMALITIES;
D O I
10.2214/AJR.11.7076
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The purpose of this article is to illustrate a wide spectrum of malignant primary and secondary pleural and pericardial diseases imaged with F-18-FDG PET/CT. CONCLUSION. A wide variety of malignant pleural and pericardial diseases can be detected, staged, and monitored by FDG PET/CT. Although the PET/CT findings are often nonspecific, the aim of this atlas is to show that the spectrum of pleural and pericardial disease that can be evaluated with PET/CT is much broader than current literature would suggest. PET/CT readers and oncologists should be aware of the wide variety of malignancies that can affect the pleura and pericardium and some of the patterns of FDG uptake that can be observed in these cases.
引用
收藏
页码:678 / 685
页数:8
相关论文
共 50 条
  • [1] Response evaluation by CT and FDG-PET/CT in malignant pleural mesothelioma
    Schaefer, N. G.
    Veit, P.
    Steinert, H.
    Stahel, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Comment on: “the FDG PET/CT score” for the diagnosis of malignant pleural effusion
    Dharmender Malik
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 5 - 6
  • [3] Is FDG-PET/CT useful for managing malignant pleural mesothelioma?
    Otsuka, Hideki
    Terazawa, Kaori
    Morita, Naomi
    Otomi, Yoichi
    Yamashita, Kyo
    Nishitani, Hiromu
    JOURNAL OF MEDICAL INVESTIGATION, 2009, 56 (1-2): : 16 - 20
  • [4] Comment on: "the FDG PET/CT score" for the diagnosis of malignant pleural effusion
    Malik, Dharmender
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (01) : 5 - 6
  • [5] A Review of the Role of FDG-PET/CT and PET/MRI in Malignant Pleural Mesothelioma
    Bural, Gonca
    Torigian, Drew
    Alavi, Abass
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [6] Pleural tuberculosis mimicking malignant pleural mesothelioma by 18F-FDG PET/CT
    Ai, Ling
    Wang, Wenjun
    Li, Yuying
    MEDICINA CLINICA, 2023, 161 (09): : 415
  • [7] The efficacy of 18F-FDG PET/CT in monitoring disease progression in malignant pleural mesothelioma
    Soyler, Y.
    Ozmen, O.
    Kabalak, P. A.
    Erturk, H.
    Ugurman, F.
    Yilmaz, U.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (01): : 3 - 9
  • [8] Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma
    Veit-Haibach, Patrick
    Schaefer, Niklaus G.
    Steinert, Hans C.
    Soyka, Jan D.
    Seifert, Burkhardt
    Stahel, Rolf A.
    LUNG CANCER, 2010, 67 (03) : 311 - 317
  • [9] Role of 18F-FDG PET/CT in Malignant Pleural Mesothelioma
    Cayvarli, H.
    Bekis, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S454 - S454
  • [10] Response evaluation in malignant pleural mesothelioma (MPM) with FDG-PET/CT
    Dellea, MMS
    Burger, C
    Hany, TF
    Seifert, B
    Jermann, M
    Kung, M
    Stahel, RA
    Steinert, HC
    von Schulthess, GK
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S408 - S408